Genertec Universal Medical Group Company Limited (5UM) — Cash Flow Reinvestment Rate
Genertec Universal Medical Group Company Limited (5UM) has a Cash Flow Reinvestment Rate of 0.11x as of December 2022, reinvesting €184.52 Million (capex €170.49 Million plus investments €-14.03 Million) from operating cash flow of €1.69 Billion. Explore Genertec Universal Medical Group Company capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Genertec Universal Medical Group Company Limited Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Genertec Universal Medical Group Company Limited across 4 annual periods. Also explore Genertec Universal Medical Group Company assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Genertec Universal Medical Group Company Limited (2022–2025)
Year-by-year capital reinvestment analysis for Genertec Universal Medical Group Company Limited. For live market cap and broader valuation context, see market cap of Genertec Universal Medical Group Company.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | €1.01 Billion | €5.78 Billion | €988.91 Million | ▼ -87.9% |
| 2024 | 1.44x | €1.64 Billion | €1.14 Billion | €1.26 Billion | ▲ +267.1% |
| 2023 | 0.39x | €1.96 Billion | €4.99 Billion | €896.83 Million | ▲ +4.0% |
| 2022 | 0.38x | €774.64 Million | €2.06 Billion | €608.09 Million | — |